Cite
HARVARD Citation
Philippe, G. et al. (2016). Development of cell‐penetrating peptide‐based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions. Biopolymers. 106 (6), pp. 853-863. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Philippe, G. et al. (2016). Development of cell‐penetrating peptide‐based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions. Biopolymers. 106 (6), pp. 853-863. [Online].